메뉴 건너뛰기




Volumn 6, Issue 1, 2011, Pages

Clinical significance in the number of involved lymph nodes in patients that underwent surgery for pathological stage III-N2 non-small cell lung cancer

Author keywords

Mediastial lymph node metastasis; Non small cell lung cancer; Number of involved lymph nodes; Postoperative prognosis; Skip metastasis; Surgical resection

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 80054855661     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-6-144     Document Type: Article
Times cited : (15)

References (31)
  • 1
    • 77955635233 scopus 로고    scopus 로고
    • Cancer statistics, 2010
    • 10.3322/caac.20073, 20610543
    • Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300. 10.3322/caac.20073, 20610543.
    • (2010) CA Cancer J Clin , vol.60 , pp. 277-300
    • Jemal, A.1    Siegel, R.2    Xu, J.3    Ward, E.4
  • 4
    • 43249091308 scopus 로고    scopus 로고
    • Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry
    • 10.1097/JTO.0b013e318164545d, 18317063
    • Ou SH, Zell JA. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry. J Thorac Oncol 2008, 3:216-27. 10.1097/JTO.0b013e318164545d, 18317063.
    • (2008) J Thorac Oncol , vol.3 , pp. 216-227
    • Ou, S.H.1    Zell, J.A.2
  • 5
    • 34548457234 scopus 로고    scopus 로고
    • International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours
    • 10.1097/JTO.0b013e31812f3c1a, 17762336
    • Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L. International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007, 2:706-14. 10.1097/JTO.0b013e31812f3c1a, 17762336.
    • (2007) J Thorac Oncol , vol.2 , pp. 706-714
    • Goldstraw, P.1    Crowley, J.2    Chansky, K.3    Giroux, D.J.4    Groome, P.A.5    Rami-Porta, R.6    Postmus, P.E.7    Rusch, V.8    Sobin, L.9
  • 6
    • 0033993435 scopus 로고    scopus 로고
    • Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group
    • 10.1378/chest.117.2.358, 10669675
    • Sause W, Kolesar P, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran W, Byhardt R, Dar AR, Turrisi A. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000, 117:358-64. 10.1378/chest.117.2.358, 10669675.
    • (2000) Chest , vol.117 , pp. 358-364
    • Sause, W.1    Kolesar, P.2    Taylor, S.3    Johnson, D.4    Livingston, R.5    Komaki, R.6    Emami, B.7    Curran, W.8    Byhardt, R.9    Dar, A.R.10    Turrisi, A.11
  • 7
    • 43449127501 scopus 로고    scopus 로고
    • Overview of chemoradiation clinical trials for locally advanced non-small cell lung cancer in Japan
    • 10.1007/s10147-007-0754-y, 18463953
    • Okamoto I. Overview of chemoradiation clinical trials for locally advanced non-small cell lung cancer in Japan. Int J Clin Oncol 2008, 13:112-6. 10.1007/s10147-007-0754-y, 18463953.
    • (2008) Int J Clin Oncol , vol.13 , pp. 112-116
    • Okamoto, I.1
  • 8
    • 19844364466 scopus 로고    scopus 로고
    • Multimodality therapy for stage III non-small-cell lung cancer
    • 10.1200/JCO.2005.03.008, 15886313
    • Farray D, Mirkovic N, Albain KS. Multimodality therapy for stage III non-small-cell lung cancer. J Clin Oncol 2005, 23:3257-69. 10.1200/JCO.2005.03.008, 15886313.
    • (2005) J Clin Oncol , vol.23 , pp. 3257-3269
    • Farray, D.1    Mirkovic, N.2    Albain, K.S.3
  • 9
    • 68549098156 scopus 로고    scopus 로고
    • International Staging Committee and Participating Institutions. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer
    • 10.1097/JTO.0b013e3181a7716e, 19458556
    • Chansky K, Sculier JP, Crowley JJ, Giroux D, Van Meerbeeck J, Goldstraw P. International Staging Committee and Participating Institutions. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol 2009, 4:792-801. 10.1097/JTO.0b013e3181a7716e, 19458556.
    • (2009) J Thorac Oncol , vol.4 , pp. 792-801
    • Chansky, K.1    Sculier, J.P.2    Crowley, J.J.3    Giroux, D.4    Van Meerbeeck, J.5    Goldstraw, P.6
  • 10
    • 21644486386 scopus 로고    scopus 로고
    • The Japanese Joint Committee of Lung Cancer Registry. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study
    • 10.1016/j.lungcan.2005.05.021, 16061304
    • Goya T, Asamura H, Yoshimura H, Kato H, Shimokata K, Tsuchiya R, Sohara Y, Miya T, Miyaoka E. The Japanese Joint Committee of Lung Cancer Registry. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer 2005, 50:227-34. 10.1016/j.lungcan.2005.05.021, 16061304.
    • (2005) Lung Cancer , vol.50 , pp. 227-234
    • Goya, T.1    Asamura, H.2    Yoshimura, H.3    Kato, H.4    Shimokata, K.5    Tsuchiya, R.6    Sohara, Y.7    Miya, T.8    Miyaoka, E.9
  • 12
    • 1842506221 scopus 로고    scopus 로고
    • Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe
    • 10.1016/j.jtcvs.2003.09.012, 15052208
    • Inoue M, Sawabata N, Takeda S, Ohta M, Ohno Y, Maeda H. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. J Thorac Cardiovasc Surg 2004, 127:1100-6. 10.1016/j.jtcvs.2003.09.012, 15052208.
    • (2004) J Thorac Cardiovasc Surg , vol.127 , pp. 1100-1106
    • Inoue, M.1    Sawabata, N.2    Takeda, S.3    Ohta, M.4    Ohno, Y.5    Maeda, H.6
  • 14
    • 34548462932 scopus 로고    scopus 로고
    • IASLC International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
    • 10.1097/JTO.0b013e31812d05d5, 17762335
    • Groome PA, Bolejack V, Crowley JJ, Kennedy C, Krasnik M, Sobin LH, Goldstraw P. IASLC International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007, 2:694-705. 10.1097/JTO.0b013e31812d05d5, 17762335.
    • (2007) J Thorac Oncol , vol.2 , pp. 694-705
    • Groome, P.A.1    Bolejack, V.2    Crowley, J.J.3    Kennedy, C.4    Krasnik, M.5    Sobin, L.H.6    Goldstraw, P.7
  • 15
    • 33847276516 scopus 로고    scopus 로고
    • Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
    • Ohe Y, Ohashi Y, Kubota K, Tamura T, Nakagawa K, Negoro S, Nishiwaki Y, Saijo N, Ariyoshi Y, Fukuoka M. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan. Ann Oncol 2007, 18:317-23.
    • (2007) Ann Oncol , vol.18 , pp. 317-323
    • Ohe, Y.1    Ohashi, Y.2    Kubota, K.3    Tamura, T.4    Nakagawa, K.5    Negoro, S.6    Nishiwaki, Y.7    Saijo, N.8    Ariyoshi, Y.9    Fukuoka, M.10
  • 16
    • 35848945663 scopus 로고    scopus 로고
    • Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer
    • 10.1097/JTO.0b013e318158d471, 17975493
    • Ilic N, Petricevic A, Arar D, Kotarac S, Banovic J, Ilic NF, Tripkovic A, Grandic L. Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer. J Thorac Oncol 2007, 2:1018-21. 10.1097/JTO.0b013e318158d471, 17975493.
    • (2007) J Thorac Oncol , vol.2 , pp. 1018-1021
    • Ilic, N.1    Petricevic, A.2    Arar, D.3    Kotarac, S.4    Banovic, J.5    Ilic, N.F.6    Tripkovic, A.7    Grandic, L.8
  • 18
    • 11144288761 scopus 로고    scopus 로고
    • Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis
    • 10.1016/j.athoracsur.2004.06.081, 15620948
    • Riquet M, Assouad J, Bagan P, Foucault C, Le Pimpec Barthes F, Dujon A, Danel C. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann Thorac Surg 2005, 79:225-33. 10.1016/j.athoracsur.2004.06.081, 15620948.
    • (2005) Ann Thorac Surg , vol.79 , pp. 225-233
    • Riquet, M.1    Assouad, J.2    Bagan, P.3    Foucault, C.4    Le Pimpec Barthes, F.5    Dujon, A.6    Danel, C.7
  • 19
    • 53849120572 scopus 로고    scopus 로고
    • The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer
    • 10.1016/j.athoracsur.2008.07.076, 19049761
    • Misthos P, Sepsas E, Kokotsakis J, Skottis I, Lioulias A. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer. Ann Thorac Surg 2008, 86:1626-30. 10.1016/j.athoracsur.2008.07.076, 19049761.
    • (2008) Ann Thorac Surg , vol.86 , pp. 1626-1630
    • Misthos, P.1    Sepsas, E.2    Kokotsakis, J.3    Skottis, I.4    Lioulias, A.5
  • 20
    • 0028216204 scopus 로고
    • A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
    • 10.1093/jnci/86.9.673, 8158698
    • Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB, Lee JS, Dhingra H, De Caro L, Chasen M, McGavran M. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994, 86:673-80. 10.1093/jnci/86.9.673, 8158698.
    • (1994) J Natl Cancer Inst , vol.86 , pp. 673-680
    • Roth, J.A.1    Fossella, F.2    Komaki, R.3    Ryan, M.B.4    Putnam, J.B.5    Lee, J.S.6    Dhingra, H.7    De Caro, L.8    Chasen, M.9    McGavran, M.10
  • 22
    • 9444287122 scopus 로고    scopus 로고
    • Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience
    • 10.1093/annonc/mdh435, 15520066, Leuven Lung Cancer Group
    • Lorent N, De Leyn P, Lievens Y, Verbeken E, Nackaerts K, Dooms C, Van Raemdonck D, Anrys B, Vansteenkiste J, . Leuven Lung Cancer Group Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience. Ann Oncol 2004, 15:1645-1653. 10.1093/annonc/mdh435, 15520066, Leuven Lung Cancer Group.
    • (2004) Ann Oncol , vol.15 , pp. 1645-1653
    • Lorent, N.1    De Leyn, P.2    Lievens, Y.3    Verbeken, E.4    Nackaerts, K.5    Dooms, C.6    Van Raemdonck, D.7    Anrys, B.8    Vansteenkiste, J.9
  • 23
    • 53649097712 scopus 로고    scopus 로고
    • Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement
    • 10.1016/j.thorsurg.2008.07.004, 19086609
    • Tieu BH, Sanborn RE, Thomas CR. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement. Thorac Surg Clin 2008, 18:403-15. 10.1016/j.thorsurg.2008.07.004, 19086609.
    • (2008) Thorac Surg Clin , vol.18 , pp. 403-415
    • Tieu, B.H.1    Sanborn, R.E.2    Thomas, C.R.3
  • 25
    • 68749106139 scopus 로고    scopus 로고
    • Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival
    • 10.1016/j.ejcts.2009.04.013, 19502079
    • Decaluwé H, De Leyn P, Vansteenkiste J, Dooms C, Van Raemdonck D, Nafteux P, Coosemans W, Lerut T. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival. Eur J Cardiothorac Surg 2009, 36:433-9. 10.1016/j.ejcts.2009.04.013, 19502079.
    • (2009) Eur J Cardiothorac Surg , vol.36 , pp. 433-439
    • Decaluwé, H.1    De Leyn, P.2    Vansteenkiste, J.3    Dooms, C.4    Van Raemdonck, D.5    Nafteux, P.6    Coosemans, W.7    Lerut, T.8
  • 27
    • 0346238665 scopus 로고    scopus 로고
    • International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
    • Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J. International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004, 350:351-60.
    • (2004) N Engl J Med , vol.350 , pp. 351-360
    • Arriagada, R.1    Bergman, B.2    Dunant, A.3    Le Chevalier, T.4    Pignon, J.P.5    Vansteenkiste, J.6
  • 30
    • 34548145056 scopus 로고    scopus 로고
    • Postoperative radiotherapy for non-small cell lung cancer
    • PORT Meta-analysis Trialists Group
    • PORT Meta-analysis Trialists Group Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2005, 18:CD002142. PORT Meta-analysis Trialists Group.
    • (2005) Cochrane Database Syst Rev , vol.18
  • 31
    • 70249139904 scopus 로고    scopus 로고
    • Post-operative radiation therapy (PORT) in completely resected non-small-cell lung cancer
    • 10.1007/s11864-009-0090-8, 19387842
    • Krupitskaya Y, Loo BW. Post-operative radiation therapy (PORT) in completely resected non-small-cell lung cancer. Curr Treat Options Oncol 2008, 9:343-56. 10.1007/s11864-009-0090-8, 19387842.
    • (2008) Curr Treat Options Oncol , vol.9 , pp. 343-356
    • Krupitskaya, Y.1    Loo, B.W.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.